FDA Inspection 1246063 — SCRIBE OPCO, INC.
The FDA completed an inspection of SCRIBE OPCO, INC. on Aug 1, 2024 in Clearwater, FL. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 1, 2024
- Fiscal Year
- 2024
- Product Type
- Devices
- Project Area
- Postmarket Assurance: Devices
- Location
- Clearwater, FL (United States)